Quadrant Capital Group’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-89
| Closed | -$4.57K | – | 2482 |
|
|
2025
Q1 | $4.57K | Hold |
89
| – | – | ﹤0.01% | 2374 |
|
|
2024
Q4 | $4.93K | Buy |
89
+83
| +1,383% | +$4.6K | ﹤0.01% | 2302 |
|
|
2024
Q3 | $198 | Buy |
+6
| New | +$198 | ﹤0.01% | 2709 |
|
|
2023
Q4 | – | Sell |
-130
| Closed | -$2.31K | – | 2783 |
|
|
2023
Q3 | $2.31K | Buy |
+130
| New | +$2.31K | ﹤0.01% | 2356 |
|